Health Canada - Federal department responsible for drug approvals and health regulation in Canada
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| ONDEXXYA | astrazeneca canada inc | Marketed | May 27, 2024 | Marketed |
| KIDS 50 CLEAR SUNSCREEN SPRAY | sun bum llc | Marketed | May 26, 2024 | Marketed |
| CLEAR SUNSCREEN FACE STICK | sun bum llc | Marketed | May 26, 2024 | Marketed |
| LABETALOL HYDROCHLORIDE INJECTION USP | Jamp Pharma Corporation | Marketed | May 24, 2024 | Marketed |
| JAMP SILODOSIN | Jamp Pharma Corporation | Marketed | May 22, 2024 | Marketed |
| TARO-FUSIDIC ACID | Taro Pharmaceuticals Inc | Marketed | May 22, 2024 | Marketed |
| IRINOTECAN HYDROCHLORIDE INJECTION, USP | generic medical partners inc | Marketed | May 22, 2024 | Marketed |
| JAMP SILODOSIN | Jamp Pharma Corporation | Marketed | May 22, 2024 | Marketed |
| ABRYSVO | Pfizer Canada Ulc | Marketed | May 22, 2024 | Marketed |
| BIONATURA | 13552802 CANADA INC. | Marketed | May 21, 2024 | Marketed |
| APO-CANDESARTAN TABLETS | Apotex Inc | Marketed | May 21, 2024 | Marketed |
| APO-CANDESARTAN TABLETS | Apotex Inc | Marketed | May 21, 2024 | Marketed |
| APO-CANDESARTAN TABLETS | Apotex Inc | Marketed | May 21, 2024 | Marketed |
| APO-CANDESARTAN TABLETS | Apotex Inc | Marketed | May 21, 2024 | Marketed |
| COSENTYX | novartis pharmaceuticals canada inc | Marketed | May 17, 2024 | Marketed |
| LACOSAMIDE INJECTION, USP | hikma canada limited | Marketed | May 17, 2024 | Marketed |
| TOBRAMYCIN INJECTION USP | Jamp Pharma Corporation | Marketed | May 16, 2024 | Marketed |
| EPTIFIBATIDE INJECTION | Juno Pharmaceuticals Corp. | Marketed | May 16, 2024 | Marketed |
| EPTIFIBATIDE INJECTION | Juno Pharmaceuticals Corp. | Marketed | May 16, 2024 | Marketed |
| TECENTRIQ SC | Hoffmann-La Roche Limited | Marketed | May 16, 2024 | Marketed |